Skip to main content
main-content

Medicine Matters oncology

Non-small-cell lung cancer

  • Patients with metastatic disease that has progressed during or following platinum-based chemotherapy

Urothelial carcinoma

  • Patients with locally advanced or metastatic disease that has progressed during or following platinum-based chemotherapy
  • Patients with disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-based chemotherapy